A UGT1A1 Genotype-Directed Study of Belinostat Pharmacokinetics and Toxicity
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Crinetics Pharmaceuticals Inc.
The First Affiliated Hospital of Xiamen University
Boston Scientific Corporation
Intergroupe Francophone de Cancerologie Thoracique
SystImmune Inc.
IDEAYA Biosciences
Molecular Partners AG
Suzhou Zelgen Biopharmaceuticals Co.,Ltd
Suzhou Zelgen Biopharmaceuticals Co.,Ltd
University of Miami
Tanabe Pharma America, Inc.
UNICANCER
Suzhou Zelgen Biopharmaceuticals Co.,Ltd
National Institutes of Health Clinical Center (CC)
Centre Hospitalier Universitaire Dijon
Phanes Therapeutics
Travera Inc
Asan Medical Center
Fudan University
GERCOR - Multidisciplinary Oncology Cooperative Group
National Institutes of Health Clinical Center (CC)
Turning Point Therapeutics, Inc.
University of Roma La Sapienza
Jagiellonian University
Suzhou Zelgen Biopharmaceuticals Co.,Ltd
Suzhou Zelgen Biopharmaceuticals Co.,Ltd
European Institute of Oncology
Fudan University
European Institute of Oncology